Mark Hediger

Mark Hediger was raised on a family farm in Southern Illinois. After completing his education at UC-Berkeley in synthetic and bio-organic chemistries, he arrived in Cambridge as a medicinal chemist. He moved from a small to a medium biotechnology setting by merger and Eli Lilly ultimately acquired the latter organization. Hediger’s expertise ranges from synthetic chemistry (including radioisotopes), molecular spectroscopies, molecular biology, target-based design, assay design/high throughput screening, ADMET, and pre-clinical and CMC program development. Forging actionable drug-discovery solutions at the interfaces of modern biology, chemistry, physics and technology is the primary mission of MEH Associates, Inc.